Computational Identification of Protein Tyrosine Phospatase-1B (PTP-1B) Inhibitors for Checking Type II Diabetes
DOI:
https://doi.org/10.37591/rrjomst.v6i3.33Abstract
Protein tyrosine phosphatases (PTPs) are a family of enzyme that comprises of about 100 proteins which catalyze dephosphorylation of phosphotyrosine residues in protein substrates. Phosphotyrosine is a central element in cell signaling, and its activity is essential for cellular homeostasis and for appropriate responses to extracellular signals. PTP-1B antagonizes insulin signaling by reducing the activation state of the insulin receptor kinase, thereby inhibiting post-receptor signaling in insulin responsive tissue. The enzyme has generated a great deal of interest as a potential drug target, and PTP-1B null mice do not accumulate fat when placed on high-fat diet in contrast to their wild-type littermates. Unfortunately, due to the ~80% homology in the catalytic domain of the PTP super family, finding novel inhibitors that are specific for PTP-1B has so far been proven difficult. Furthermore, the progress towards developing an efficient PTP-1B antagonist for therapeutic use has also been hampered by low bioavailability of inhibitor tested in vivo. This led us to discover PTP-1B inhibitors computationally. We have screened a vast library of compounds. Virtual screening was performed and further molecular docking and ADMET studies have been done to find out best possible drug candidate.
Keywords: Phosphatases, enzyme, inhibitors, virtual screening, molecular docking
Cite this Article
Bharti DK, Chaudhary KK, Gupta SK et al. Computational identification of protein tyrosine phospatase-1B (PTP-1B) inhibitors for checking type II diabetes. Research & Reviews: Journal of Medical Science and Technology. 2017; 6(3): 21–25p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |